Thus, maintenance of the glutathione pool in a relatively more reduced status, preservation of Mn–SOD activity, and attenuation of UCP2 content reduction in losartan-treated, but not in amlodipine-treated, SHR support a link between Ang II inhibition and mitochondria in renal damage protection in hypertension [61]. This evidence concerns the gene SOD1 and hypertensive disorder.